1. Abrams, P. G., and Oldham, R. K., 1985, Monoclonal antibody therapy of solid tumors, in: Monoclonal Antibody Therapy of Human Cancer, ( K. A. Foon and A. C. Morgan, Jr., eds.), pp. 103–120, Martins Nijhoff, Boston.
2. Black, C. D. V., Atcher, R. W., Barbet, J., Brechbiel, M. W., Holton, O. D., III, Hines, J. J., Gansow, O. A., and Weinstein, J. N., 1988, Selective ablation of B lymphocytes in vivo by an alpha emitter, 212bismuth, chelated to a monoclonal antibody, Antibody Immunoconjugates, Radiopharm. 1: 43–53.
3. Blasberg, R. G., Nakagawa, H., Bourdon, M. A., Groothuis, D. R., Patlak, C. S., and Binger, D. D., 1987, Regional localization of a glioma-associated antigen defined by monoclonal antibody. 8106 in vivo: Kinetics and implications for diagnosis and therapy, Cancer Res. 47: 4432–4443.
4. Bundgaard, M., 1980, Transport pathways in capillaries—hi search of pores, Annu. Rev. Physiol. 42: 325–336.
5. Covell, D. G., Barbet, J., Holton, O. D., III, Black, C. D. V., and Weinstein, J. N., 1986, The pharmacokinetics of monoclonal IgG1, F(ab’)2, and Fab’ in mice, Cancer Res. 46: 3969–3978.